Company profile: Claritas Genomics
1.1 - Company Overview
Company description
- Provider of genomics solutions, established as a new venture through a partnership between Boston Children's Hospital and Life Technologies Corp.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Claritas Genomics
Lexent Bio
HQ: United States
Website
- Description: Provider of novel liquid biopsy technology for cancer diagnosis and treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexent Bio company profile →
Verge Genomics
HQ: United States
Website
- Description: Provider of an AI-powered, all-in-human drug discovery platform (CONVERGE®) integrating proprietary human genomics and computational tools to predict new drugs; developer of VRG50635, a PIKfyve inhibitor for ALS; and collaborator with industry and academic partners, including Alexion/AstraZeneca Rare Disease, Eli Lilly, and SITraN, to co-develop clinical-stage and novel therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verge Genomics company profile →
Lentigen Technology
HQ: United States
Website
- Description: Provider of gene delivery technologies and CDMO services for cell and gene therapy products, offering lentiviral vector technology for therapeutic, vaccine, and research applications; lentiviral vector design, evaluation, and scalable manufacturing; process development and clinical manufacturing; assay development via automated flow cytometry; and regulatory support from pre-IND to approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lentigen Technology company profile →
Envisagenics
HQ: United States
Website
- Description: Provider of AI/ML-driven RNA sequencing analysis solutions to accelerate therapeutic development. Offers SpliceCore, a platform that analyzes RNA splicing events to discover drug targets, and SpliceIO, a machine learning module that identifies RNA splicing-derived neoepitopes for immunotherapy, reducing biomedical data complexity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Envisagenics company profile →
Sequenta
HQ: United States
Website
- Description: Provider of clinical diagnostics and immune profiling tools based on a platform for understanding immune system status. Products include clonoSEQ for MRD detection and monitoring in multiple myeloma, acute lymphoblastic leukemia, and chronic lymphocytic leukemia; immunoSEQ for sequencing T- and B-cell receptors; T-Detect to identify recent or past infections, including COVID-19; and an Immune Medicine Platform mapping immune receptors to antigens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sequenta company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Claritas Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Claritas Genomics
2.2 - Growth funds investing in similar companies to Claritas Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Claritas Genomics
4.2 - Public trading comparable groups for Claritas Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →